Quantcast
Home > Quotes > EDAP
EDAP

EDAP TMS S.A. American Depositary Shares (EDAP) Quote & Summary Data

$3.225
*  
0.005
0.16%
Get EDAP Alerts
*Delayed - data as of Aug. 23, 2019  -  Find a broker to begin trading EDAP now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    EDAP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 3.28 / $ 3.15
Share Volume
36,969
50 Day Avg. Daily Volume
154,702
Previous Close
$ 3.22
52 Week High / Low
$ 5.42 / $ 1.35
Market Cap
93,518,118
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
36,969
50 Day Avg. Daily Volume:
154,702

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
40.25
Earnings Per Share (EPS):
$ -0.01

Trading Range

The current last sale of $3.225 is 138.89% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.28 $ 5.42
 Low: $ 3.15 $ 1.35

Company Description (as filed with the SEC)

We develop and market robotic HIFU devices, advanced choices for the treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option for localized prostate cancer (T1-T2) with a low occurrence of side effects. Our HIFU devices are also used for patients who failed a radiotherapy treatment. In addition, we are developing a HIFU platform for the treatment of various types of tumors including rectal endometriosis, liver and pancreatic cancer, but also breast and gynecological tumors. We also produce and commercialize medical equipment for the treatment of urinary tract stones using ESWL and distribute other types of urology devices in certain countries. History and Development of the Company Our legal name is EDAP TMS S.A. and our commercial name is EDAP TMS. EDAP TMS S.A.  ... More ...  



Risk Grade

Where does EDAP fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.17
Open Date:
Aug. 23, 2019
Close Price:
$ 3.24
Close Date:
Aug. 23, 2019


Consensus Recommendation

Analyst Info